📺 Looking to dive deeper into your favourite Deep Tech topics? Don’t forget to check out our YouTube channel!
🔭 Take that first step! Visit Deep Tech Central for career and development opportunities.
Each year, close to 20 million people around the world hear the words, “You have cancer.” Regular screening plays a vital role in early cancer detection and treatment, yet the uptake of such tests remains low. In Singapore, for example, a recent survey found that only about four in 10 women aged 50 to 69 regularly go for a mammogram.
Now, however, Singaporean precision medicine startup Lucence has developed a range of quick, non-invasive blood tests that can alert people to cancer DNA and different mutations for earlier cancer detection when potentially curable.
